Health ❯ Healthcare ❯ Diabetes

Type 1 Diabetes

Type 2 Diabetes Insulin Treatment Insulin Therapy Teplizumab Insulin Hyperglycemia COVALENT-112 Insulin Production Immune Modulation Adult Management

Novo Nordisk Launches Once-Weekly Insulin Awiqli in India

The company says a weekly basal shot could lower barriers to insulin initiation for millions of adults with diabetes in India.

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

FDA Approves Langlara as Interchangeable Biosimilar to Lantus

Stanford’s Low-Radiation Transplant Combo Reverses Type 1 Diabetes in Mice

CRISPR Therapeutics’ Pipeline Pitched as Path to One-Time Heart Risk Treatments

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

Peru Moves to Buy 47,000 Units of NPH Insulin as Shortage Imperils Type 1 Patients

UK Study Validates Finger-Prick Screening for Early Type 1 Diabetes, Prompting NHS Clinics

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

AHA Trial Signals Higher One-Year Events With Ticagrelor Than Prasugrel in Diabetic Stent Patients

Neil Diamond Receives Carousel Ball Honor, Delivers Rare Sweet Caroline Duet

NHS Orders 55,000 Diabetes Retests After Faulty Lab Machines Trigger False Results

Tandem Diabetes Announces Urgent Medical Device Correction for t:slim X2 Pumps

UK Administers First Teplizumab Immunotherapy to Adult Type 1 Diabetes Patient

NHS Launches GP Pilot to Detect Pancreatic Cancer Before Symptoms Emerge

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia

Weekly Insulin Shots Match Daily Injections in Diabetes Management